...
首页> 外文期刊>Cancer research: The official organ of the American Association for Cancer Research, Inc >Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer.
【24h】

Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer.

机译:全基因组染色质特征的分析揭示了大肠癌中MicroRNA基因的表观遗传调控。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Altered expression of microRNAs (miRNA) occurs commonly in human cancer, but the mechanisms are generally poorly understood. In this study, we examined the contribution of epigenetic mechanisms to miRNA dysregulation in colorectal cancer by carrying out high-resolution ChIP-seq. Specifically, we conducted genome-wide profiling of trimethylated histone H3 lysine 4 (H3K4me3), trimethylated histone H3 lysine 27 (H3K27me3), and dimethylated histone H3 lysine 79 (H3K79me2) in colorectal cancer cell lines. Combining miRNA expression profiles with chromatin signatures enabled us to predict the active promoters of 233 miRNAs encoded in 174 putative primary transcription units. By then comparing miRNA expression and histone modification before and after DNA demethylation, we identified 47 miRNAs encoded in 37 primary transcription units as potential targets of epigenetic silencing. The promoters of 22 transcription units were associated with CpG islands (CGI), all of which were hypermethylated in colorectal cancer cells. DNA demethylation led to increased H3K4me3 marking at silenced miRNA genes, whereas no restoration of H3K79me2 was detected in CGI-methylated miRNA genes. DNA demethylation also led to upregulation of H3K4me3 and H3K27me3 in a number of CGI-methylated miRNA genes. Among the miRNAs we found to be dysregulated, many of which are implicated in human cancer, miR-1-1 was methylated frequently in early and advanced colorectal cancer in which it may act as a tumor suppressor. Our findings offer insight into the association between chromatin signatures and miRNA dysregulation in cancer, and they also suggest that miRNA reexpression may contribute to the effects of epigenetic therapy.
机译:microRNA(miRNA)的表达改变通常发生在人类癌症中,但其机制通常了解甚少。在这项研究中,我们通过进行高分辨率ChIP-seq检验了表观遗传机制对结直肠癌中miRNA失调的影响。具体来说,我们在大肠癌细胞系中对三甲基化组蛋白H3赖氨酸4(H3K4me3),三甲基化组蛋白H3赖氨酸27(H3K27me3)和二甲基化组蛋白H3赖氨酸79(H3K79me2)进行了全基因组分析。将miRNA表达谱与染色质特征结合起来,使我们能够预测174个假定的初级转录单位中编码的233个miRNA的活性启动子。然后通过比较DNA去甲基化前后的miRNA表达和组蛋白修饰,我们鉴定了以37个主要转录单位编码的47个miRNA作为表观遗传沉默的潜在靶标。 22个转录单位的启动子与CpG岛(CGI)相关,所有这些在结肠直肠癌细胞中均被高度甲基化。 DNA去甲基化导致沉默的miRNA基因上的H3K4me3标记增加,而在CGI甲基化的miRNA基因中未检测到H3K79me2的恢复。 DNA去甲基化还导致许多CGI甲基化的miRNA基因中的H3K4me3和H3K27me3上调。在我们发现失调的miRNA中,其中许多与人类癌症有关,miR-1-1在早期和晚期大肠癌中经常被甲基化,其中它可能起到抑癌作用。我们的发现为癌症中染色质特征与miRNA失调之间的关联提供了深刻的见解,并且他们还暗示miRNA的重新表达可能有助于表观遗传疗法的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号